>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle

CompanyHeadlineTime (ET)
CATAvoid Zillow: This Infrastructure Redirect Is a “No-Brainer” Buy as the Housing Market Stalls06/05 20:22
ELWTELWT Investor News: If You Have Suffered Losses in Elauwit Connection, Inc. (NASDAQ: ELWT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights06/05 20:17
WGSGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. (WGS)06/05 20:00
CVLTCVLT INVESTOR DEADLINE: Commvault Systems, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit06/05 20:00
LCIDLCID SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Lucid Group, Inc. Investors - Contact Kirby McInerney LLP by July 28, 202606/05 20:00
VRRMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors it Has Filed a Complaint to Recover Losses Suffered by Purchasers of Verra Mobility Corporation Common Stock and Sets a Lead Plaintiff Deadline of August 4, 202606/05 19:59
TBBKNortheast Community Bancorp: A Buy As Deposit Inflows Continue In Q1 202606/05 19:58
ADBEPreviewing the 2026 Q2 Earnings Season06/05 19:52
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials06/05 19:48
Purecore Announces up to $1.5 Million Non-Brokered Private Placement06/05 19:40
DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information06/05 19:38
MNKDData at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind's Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems06/05 19:35
MNKDData at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with Automated Insulin Delivery (AID) Systems06/05 19:35
GLPHengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 202606/05 19:32
GLPBiomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study06/05 19:32

Market News ×
Loading news…